135 related articles for article (PubMed ID: 9352538)
1. Reassessment of FDG uptake in tumor cells: high FDG uptake as a reflection of oxygen-independent glycolysis dominant energy production.
Waki A; Fujibayashi Y; Yonekura Y; Sadato N; Ishii Y; Yokoyama A
Nucl Med Biol; 1997 Oct; 24(7):665-70. PubMed ID: 9352538
[TBL] [Abstract][Full Text] [Related]
2. Energy metabolism of leukemia cells: glycolysis versus oxidative phosphorylation.
Suganuma K; Miwa H; Imai N; Shikami M; Gotou M; Goto M; Mizuno S; Takahashi M; Yamamoto H; Hiramatsu A; Wakabayashi M; Watarai M; Hanamura I; Imamura A; Mihara H; Nitta M
Leuk Lymphoma; 2010 Nov; 51(11):2112-9. PubMed ID: 20860495
[TBL] [Abstract][Full Text] [Related]
3. 18F-fluorodeoxyglucose uptake in tumor.
Khan N; Islam MM; Mahmood S; Hossain GA; Chakraborty RK
Mymensingh Med J; 2011 Apr; 20(2):332-42. PubMed ID: 21522112
[TBL] [Abstract][Full Text] [Related]
4. Posthypoxic reoxygenation-induced neurotoxicity prevented by free radical scavenger and NMDA/non-NMDA antagonist in tandem as revealed by dynamic changes in glucose metabolism with positron autoradiography.
Murata T; Omata N; Fujibayashi Y; Waki A; Sadato N; Yoshimoto M; Wada Y; Yonekura Y
Exp Neurol; 2000 Aug; 164(2):269-79. PubMed ID: 10915566
[TBL] [Abstract][Full Text] [Related]
5. Differential toxic mechanisms of 2-deoxy-D-glucose versus 2-fluorodeoxy-D-glucose in hypoxic and normoxic tumor cells.
Kurtoglu M; Maher JC; Lampidis TJ
Antioxid Redox Signal; 2007 Sep; 9(9):1383-90. PubMed ID: 17627467
[TBL] [Abstract][Full Text] [Related]
6. Determination of 2-fluoro-2-deoxy-D-glucose uptake and ATP level for evaluating drug effects in neoplastic cells.
Minn H; Kangas L; Knuutila V; Paul R; Sipilä H
Res Exp Med (Berl); 1991; 191(1):27-35. PubMed ID: 2034887
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of 2-halogen substituted D-glucose analogs in blocking glycolysis and killing "hypoxic tumor cells".
Lampidis TJ; Kurtoglu M; Maher JC; Liu H; Krishan A; Sheft V; Szymanski S; Fokt I; Rudnicki WR; Ginalski K; Lesyng B; Priebe W
Cancer Chemother Pharmacol; 2006 Dec; 58(6):725-34. PubMed ID: 16555088
[TBL] [Abstract][Full Text] [Related]
8. FDG accumulation and tumor biology.
Pauwels EK; Ribeiro MJ; Stoot JH; McCready VR; Bourguignon M; Mazière B
Nucl Med Biol; 1998 May; 25(4):317-22. PubMed ID: 9639291
[TBL] [Abstract][Full Text] [Related]
9. Energy system interaction and relative contribution during maximal exercise.
Gastin PB
Sports Med; 2001; 31(10):725-41. PubMed ID: 11547894
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the role of hexokinase type II in cellular proliferation and apoptosis using human hepatocellular carcinoma cell lines.
Ahn KJ; Hwang HS; Park JH; Bang SH; Kang WJ; Yun M; Lee JD
J Nucl Med; 2009 Sep; 50(9):1525-32. PubMed ID: 19690031
[TBL] [Abstract][Full Text] [Related]
11. Regulation of glucose uptake in lymphoma cell lines by c-MYC- and PI3K-dependent signaling pathways and impact of glycolytic pathways on cell viability.
Broecker-Preuss M; Becher-Boveleth N; Bockisch A; Dührsen U; Müller S
J Transl Med; 2017 Jul; 15(1):158. PubMed ID: 28724379
[TBL] [Abstract][Full Text] [Related]
12. Glucose transporter protein-independent tumor cell accumulation of fluorine-18-AFDG, a lipophilic fluorine-18-FDG analog.
Waki A; Fujibayashi Y; Magata Y; Yokoyama A; Sadato N; Tsuchida T; Ishii Y; Yonekura Y
J Nucl Med; 1998 Feb; 39(2):245-50. PubMed ID: 9476929
[TBL] [Abstract][Full Text] [Related]
13. Differential sensitivity to 2-deoxy-D-glucose between two pancreatic cell lines correlates with GLUT-1 expression.
Maher JC; Savaraj N; Priebe W; Liu H; Lampidis TJ
Pancreas; 2005 Mar; 30(2):e34-9. PubMed ID: 15714127
[TBL] [Abstract][Full Text] [Related]
14. [Uptake of FDG (2-fluoro-2-deoxy-D-glucose) as a tumor imaging agent into erythrocytes and accumulation of FDG in tumor cells].
Minosako Y; Nemoto M; Ino S; Shirakami Y; Kurami M
Kaku Igaku; 2003 Feb; 40(1):23-30. PubMed ID: 12701204
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia-Induced increase in FDG uptake in MCF7 cells.
Burgman P; Odonoghue JA; Humm JL; Ling CC
J Nucl Med; 2001 Jan; 42(1):170-5. PubMed ID: 11197971
[TBL] [Abstract][Full Text] [Related]
16. Oxidized low-density lipoprotein stimulates macrophage 18F-FDG uptake via hypoxia-inducible factor-1α activation through Nox2-dependent reactive oxygen species generation.
Lee SJ; Thien Quach CH; Jung KH; Paik JY; Lee JH; Park JW; Lee KH
J Nucl Med; 2014 Oct; 55(10):1699-705. PubMed ID: 25214643
[TBL] [Abstract][Full Text] [Related]
17. Heterogeneity in 2-deoxy-D-glucose-induced modifications in energetics and radiation responses of human tumor cell lines.
Dwarkanath BS; Zolzer F; Chandana S; Bauch T; Adhikari JS; Muller WU; Streffer C; Jain V
Int J Radiat Oncol Biol Phys; 2001 Jul; 50(4):1051-61. PubMed ID: 11429233
[TBL] [Abstract][Full Text] [Related]
18. Lactic acidosis switches cancer cells from aerobic glycolysis back to dominant oxidative phosphorylation.
Wu H; Ying M; Hu X
Oncotarget; 2016 Jun; 7(26):40621-40629. PubMed ID: 27259254
[TBL] [Abstract][Full Text] [Related]
19. Under normoxia, 2-deoxy-D-glucose elicits cell death in select tumor types not by inhibition of glycolysis but by interfering with N-linked glycosylation.
Kurtoglu M; Gao N; Shang J; Maher JC; Lehrman MA; Wangpaichitr M; Savaraj N; Lane AN; Lampidis TJ
Mol Cancer Ther; 2007 Nov; 6(11):3049-58. PubMed ID: 18025288
[TBL] [Abstract][Full Text] [Related]
20. Aerobic glycolysis: meeting the metabolic requirements of cell proliferation.
Lunt SY; Vander Heiden MG
Annu Rev Cell Dev Biol; 2011; 27():441-64. PubMed ID: 21985671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
